Markets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Overview
Buy Sell Zone
F&O
Financials
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Share Price History
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
About
Zydus Lifesciences Ltd.
NSE: ZYDUSLIFE
|
BSE: 532321
|
ISIN: INE010B01027
|
Industry: Pharmaceuticals
US FDA Approval
High Loss High Volume
|
Falling Comet
822.1000
-61.05
(
-6.91
%)
NSE
Apr 16, 2025
15:31 PM
Near 52W Low of ₹795.00
Volume:
10.3M
High volume+loss today
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
Zydus Lifesciences Ltd.
20 Mar 2024
US FDA Approval
High Loss High Volume
822.10
-6.91%
Zydus Life
Buy:
Zydus Lifesciences Ltd.
by
Sharekhan
Target: 1100
Target
Sharekhan
Zydus Lifesciences Ltd. average weekly volume is high.
More from Zydus Lifesciences Ltd.
Recommended
Top five: Stocks that could outperform in upcoming results | Screener: Stocks with high durability scores, high target …
The Baseline |
16 Apr 2025, 05:53PM
Market closes higher, Yes Bank receives a Rs 244.2 crore tax demand for AY16-17
Trendlyne Marketwatch |
16 Apr 2025, 04:04PM
Earnings Call Transcript - Cadila Healthcare
|
14 Feb 2020